Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Naltrexone for Central Neuropathic Pain After Spinal Cord Injury
NCT06723561Phase 2Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Feb 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naltrexone in central neuropathic pain (CNP), sponsored by Medical College of Wisconsin. Started Feb 2025; status: completed.
02
Drugs
naltrexone
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on NCT06723561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06723561.